ABSTRACT
ndovascular therapy for intracranial aneurysms has been widely used since the International Subarachnoid Aneurysm Trial. 1 The number of cases of coil embolization for aneurysms is increasing, and the stent-protection technique has widened the applicability to cases that had been otherwise difficult to treat with conventional coil embolization. 2 Nevertheless, there is a risk of coil compaction or in-stent restenosis after stent-assisted coil embolization. X-ray digital subtraction angiography is the optimal technique used to examine these adverse events, and it is commonly used as a follow-up tool after using an intracranial stent. However, DSA presents some unavoidable risks related to the catheter procedure, radiation, and contrast media. [3] [4] [5] 3D time-of-flight MR angiography is widely used for the assessment of cerebral vascular diseases and has also been examined as a noninvasive substitute for DSA. [6] [7] [8] [9] These studies generally reported difficulty in visualizing flow in a stent with TOF MRA because of magnetic susceptibility and radiofrequency shielding, though some beneficial aspects were observed in assessing the residual lumen of aneurysms. As a novel follow-up tool after stent-assisted coil embolization, we applied MRA by using a Silent Scan algorithm (GE Healthcare, Milwaukee, Wisconsin) that contains an ultrashort TE combined with an arterial spin-labeling technique (Silent MRA). In this situation, visualizing flow means visualizing arterial geometry and patency. It does not mean directly visualizing blood flow rate. The purpose of this study was to determine whether Silent MRA can visualize flow in an intracranial stent placed at the anterior circulation.
MATERIALS AND METHODS
Patients treated by stent-assisted coil embolization for unruptured aneurysms in the anterior circulation were examined, and 10 consecutive patients who underwent 2 types of MRAs (Silent MRA and TOF MRA) from March 1 to June 30, 2014, were included in this study. One patient with an anterior communicating artery aneurysm was excluded because the patient experienced stent occlusion during the follow-up period. Written informed consent was not required for this study because of its retrospective observational design. Although the details of the Silent Scan algorithm were undisclosed, the arterial spin-labeling technique is used as a preparation pulse, and data acquisition is based on a 3D radial scan. 10 In the Silent Scan, a control image is first scanned before the labeling pulse, followed by a labeled image. The control and labeled images are subtracted to yield an angiographic image.
Two neuroradiologists independently reviewed the MRAs and rated the visual conditions around the flow in each stent subjectively on a 4-point scale as follows: 1, not visible (almost no signal in the stent); 2, poor (structures are slightly visible but with significant blurring or artifacts, not diagnostic); 3, good (goodquality diagnostic information with minimal blurring or artifacts); or 4, excellent (excellent-quality diagnostic information; the shape of depiction is nearly equal to that of DSA). The scores of the 2 observers were averaged, and a paired t test was performed in the statistical analysis of the subjective scores for flow in a stent. The latest DSA image was used as a reference standard. The average of the interval between the latest DSA and MRAs was 7.33 months (range, 1 day to 15 months), and the interval between the aneurysm treatment and MRAs was 18.67 months (range, 1 day to 45 months). The level of interobserver agreement in the evaluation was analyzed by weighted statistics. 
RESULTS
The mean score of Silent MRA was 3.44 Ϯ 0.53, and for TOF MRA, it was 1.44 Ϯ 0.46 (P Ͻ .001). Both observers gave Silent MRA higher scores than TOF MRA for flow in a stent in all cases. Interobserver agreement was good ( ϭ 0.963). Of note, the Silent MRA depictions of the neck remnant in 4 cases were similar to those of DSA, while TOF MRA showed only a small depiction of the neck remnant. Figures  1-5 show the DSA, Silent MRA, and TOF MRA images for each case, respectively. Silent MRA and TOF MRA images were processed to maximum intensity projections, and surrounding vessels were removed to make them similar to those on DSA.
DISCUSSION
In this study, we found that Silent MRA was superior to TOF MRA for visualizing flow in a stent in all 9 observed patients with anterior circulation aneurysms.
In the anterior circulation, the tortuosity and diameter of the vessel are different from those in the posterior circulation. The effect of magnetic susceptibility by stent or coil may differ between the anterior and posterior circulations. Thus, we believe that there is a need to distinguish these regions when assessing flow in a stent.
The most important characteristic of a Silent Scan is the ultrashort TE (TE ϭ 0.016 ms). Ultrashort TE imaging can decrease magnetic susceptibility and visualize short T2 tissues such as the musculoskeletal system, lung parenchyma, or carotid plaque. [11] [12] [13] In Silent MRA, the ultrashort TE can minimize the phase dispersion of the labeled blood flow signal in the voxel space and decrease magnetic susceptibility. Accordingly, the artifacts from stents or coils are diminished; this change enables visualization of flow in a stent. The effect of the disturbed flow in TOF MRA may also decrease. Gönner et al 14, 15 reported that ultrashort TE reduced the artifacts after coiling or stent placement, though a TE of 2.4 ms was used in that study.
In Silent MRA, the angiographic image is obtained by subtraction of images scanned before and after labeling. Thus, static tissue such as a thrombus cannot be detected in Silent MRA. Conversely, in TOF MRA, thrombus in a stent might be detected as a high-signal-intensity area. Compared with TOF MRA, Silent MRA images are easy to interpret because they consist of only the labeled blood flow signal. Takayama et al 16 reported that contrast-enhanced MRA is useful when visualizing flow in a stent, though DSA remains a superior follow-up tool for stent-assisted coil embolization. Also, while rare, contrast agents might induce serious adverse events such as anaphylaxis or nephrogenic systemic fibrosis. There are some limitations to this study. We only examined flow in a stent, though Mizuki et al 17 reported that Silent MRA was similar to TOF MRA for assessment of flow outside a stent. Wu et al 18 also reported the feasibility of MRA by using arterial spin-labeling and 3D radial scan data acquisition, which might be somewhat similar to Silent MRA. The average interval between MRA and DSA as a standard of reference is quite long (up to 15 months), which limits the validity of this comparison. Thus, MRA images might not reflect the exact condition of flow in a stent. We were also unable to compare Silent MRA and contrast-enhanced MRA. Finally, we included only cases with a closed-cell-design Enterprise stent in this study. Future studies are required to examine open-cell-design stents because the stent form might produce differences in the MRA images. 19 These study results may only be preliminary due to the small number of cases examined, limited to the anterior circulation and only 1 stent design. For potential replacement of TOF or contrastenhanced MRA for aneurysm follow-up imaging after treatment, one must analyze not only in-stent flow but also aneurysm occlusion status. We have planned a prospective study to define the situations under which Silent MRA can replace TOF MRA.
CONCLUSIONS
Silent MRA could visualize flow in an intracranial stent at the anterior circulation more effectively than TOF MRA. Further studies are required to determine the factors that affect MRA images and the most appropriate scan parameters to visualize flow in a stent. Silent MRA might be useful for the follow-up imaging after stent-assisted coil embolization, though some limitations remain to be examined.
